Monday, March, 18, 2019 06:38:58

Category: Health

Enesi Pharma forms an R&D collaboration with Public Health England

Enesi Pharma, a UK-based pharmaceutical firm focused on manufacturing novel injectable solid-dose vaccines, has reportedly announced to have formed a research and development collaboration with Public Health England (PHE). As per trusted sources, the partnership would focus on developing and evaluating unique solid-dose formulations of …

Cobra Biologics with GE Healthcare and CPI to develop AAV vectors

Cobra Biologics, an international biologics and pharmaceuticals contract development and manufacturing organization recently announced that it will be collaborating with UK-based technology innovation foundation, Centre for Process Innovation (CPI) and GE Healthcare Life Sciences. The aim of the three-way partnership is to increase the strength …

Tris Pharma acquires NextWave Pharmaceuticals, expands ADHD portfolio

Tris Pharma, technology-based therapeutic products developer recently acquired NextWave Pharmaceuticals, a subsidiary of Pfizer, the American pharmaceutical corporation. The sum involved in the acquisition has not been disclosed. According to reliable sources, the acquisition will enable Tris Pharma to expand its product offering in the …

Ariel launches genomic tool for early diagnosis of pancreatic illness

Ariel Precision Medicine Inc., a Pennsylvania-based digital health care company, has reportedly announced the launch of a new cloud-based genomic tool ArielDx® that would simplify diagnosis and treatment of pancreatic diseases. Reports cite, ArielDx is already available for purchase on the company’s website through prescription …

Roche announces global availability of FoundationOne®Liquid

Roche AG, a Swiss multinational healthcare company has recently announced the availability of a next-gen liquid biopsy test, FoundationOne®Liquid. The Swiss company also claims that the liquid biopsy would offer patients suffering with solid tumors a quick and convenient testing option, just by diagnosing a single …

Amicus Therapeutics cuts deal with Celenex, enters gene therapy

Amicus Therapeutics has recently unveiled that it has acquired Celenex, a clinical-stage gene therapy company and a spin out of the Ohio-based Nationwide Children’s Hospital, in a multimillion dollar deal. Reportedly, the deal expands Amicus portfolio of 10 gene therapy programs that are originally discovered …